Premium Diagnostics Market Research Reports
Some of Our Customers, Over The Past 2-Decades
Global Clinical Medical Laboratory Services Market
Published November 2024 – 367 pages
“Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides. 2025 to 2029“
The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
INFECTIOUS DISEASE IVD MARKET REVIEW REPORT
Published September 2024 – 356 pages
MARKETS BY DISEASE, BY TYPE (POC/LAB), BY TECHNOLOGY (MOLECULAR, IMMUNOASSAY, PANELS), AND BY COUNTRY; IMPORTANT TRENDS, COMPANY PROFILES AND MORE
The report reveals over a dozen infectious disease areas that beat growth in the IVD market, including some testing areas that are doubling or tripling the revenue growth of the market.
ARTIFICIAL INTELLIGENCE IN IVD MARKETS
Published June 2024 – 540 pages
BY APPLICATION, BY TECHNOLOGY AND BY USER. WITH EXECUTIVE AND CONSULTANT GUIDES 2024-2028
Learn all about how players are jockeying for position in a market that is being created from scratch. Some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity, where the right diagnostic with the right support can command premium pricing.
This report provides data that analysts and planners can use. Hundreds of pages of information, including a complete list of United States Medicare Fee Payment Schedules to help understand the new pricing for nucleic acid-based tests.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
SYNDROMIC MULTIPLEX PANELS MARKETS
Published January 2024 – 555 pages
Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place and by Product. With Market Analysis and Executive Guides
Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
CONTRACT MANUFACTURING IN IVD MARKETS
Published November 2024 – 50 pages
BY APPLICATION, BY TECHNOLOGY AND BY COUNTRY. TRENDS, KEY MARKET GUIDANCE AND FORECASTS 2024-2029
This report, Contract Manufacturing in IVD, provides a comprehensive look at the marketplace for these services. As contract manufacturers do not generally publish revenues, this report is assembled as the result of interviews with contract organizations manufacturing for OEMs, assessed and synthesized by a knowledgeable IVD expert with contacts in manufacturing
LIQUID BIOPSY MARKETS “Has Liquid Biopsy crossed the chasm ?”
Published August 2024 – 585 pages
“LIQUID BIOPSY MARKETS BY CANCER, USAGE, BIOMARKER, PLACE, & PRODUCT WITH PRICE AND VOLUME OUTLOOK. INCLUDING EXECUTIVE AND CONSULTANT GUIDES AND CUSTOMIZED FORECASTING AND ANALYSIS 2024-2028″
The Screening, Diagnostic, Therapy Selection, Minimal Residual Disease and Screening Market Potential are all explored in this report. We look at Price and Volume Outlooks by type of cancer. This report provides detailed analysis.
Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
Metagenomic Markets
Published January 2024 – 364 pages
“A game changer in diagnostics? New technology changes viewpoint on infections…”
Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2025 to 2029″
Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. Metagenomic Testing looks at all the genetic material in a sample. In the process it learns about infection, cancer, antimicrobial resistance, and the patient genome. It’s a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
SEPSIS MARKETS
Published June 2024 – 540 pages
BY APPLICATION, BY TECHNOLOGY AND BY USER. WITH EXECUTIVE AND CONSULTANT GUIDES 2024-2028
Diagnostics for sepsis are urgently needed and improvements are a constant concern. This creates an opportunity for test makers. But how to sum up this opportunity for reasonable business planning efforts? This report, Sepsis Markets, is a comprehensive review of the industry. The report looks at both the challenges and opportunities in the diagnostics for sepsis.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
IMMUNOASSAY MARKETS. Strategies and Trends. 2024 to 2028
Published April 22, 2024 – 409 pages
IMMUNOASSAY MARKETS. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive and Consultant Guides. 2024 to 2028
The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
HOME DIAGNOSTICS MARKETS Strategies and Trends. 2024 to 2028
Published June 2024 – 392 pages
Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides,
2024 to 2028
Rapid at home testing opens up new market.
Genetic DTC testing led the way. Now diagnostic testing is moving directly to the consumer. New technology has changed the picture on how and where testing is done. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and the learn about the players.
Exciting technical developments especially in the seesaw between different analytic technology, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even newer technology is on the horizon.
The report has hundreds of pages of information.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
Flow Cytometry Markets 2025 to 2029
Published November 2024 – 405 pages
“Immuno-oncology frontier and liquid biopsy combine to create enormous new market demand.…”
Flow Cytometry is a mainstay of analytical methods to study cells, but growth is now accelerating as new immuno-oncology and liquid biopsy markets create unprecedented investment in the race to cure cancer. Research vs. Clinical, Bead vs. Gel, its all here in this comprehensive report.
On top of this new genome based knowledge is fostering a new generation of scientific exploration of single cells. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.
The technology is moving faster than the market. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
COMPANION DIAGNOSTIC MARKETS
Published June 2024 – 546 pages
THE FUTURE OF DIAGNOSTICS BY APPLICATION, TECHNOLOGY AND FUNDING. WITH EXECUTIVE AND CONSULTANT GUIDES 2024-2028
Companion Diagnostics are changing the diagnostics industry. Whole new markets are emerging. Diagnostic and Therapeutic partnerships. Find out the latest outlook for this important market.
The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country or specific area in the world is available to purchasers of the report.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
In Vitro Diagnostic Quality Control Market
Published June 2024 – 367 pages
“New technology, new market segments driving growth…..”
The IVD Quality Control industry rose to the challenge of the pandemic. Now new opportunities abound in this established industry that is immune from recession. New technology and new segments are driving runaway growth. Understand the opportunities and the threats in this comprehensive report.
The report provides data that analysts and planners can use. Hundreds of pages of information including detailed information on clinical laboratory trends and the role of IVD. Forecast demand for new testing regimes or technologies.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
All report data is available in Excel format on request.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
Proteomic Biomarker Analytics Markets
Published February 2024 – 303 pages
“Proteomic Analytics is the new frontier in biotechnology. New large market opportunities…..”
Where genomics can’t find all the answers proteomics is stepping up to the plate.
Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.
All report data is available in Excel format on request.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.